OTCMKTS:IVITF

Invictus MD Strategies Stock Forecast, Price & News

$0.05
+0.01 (+28.57 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.04
Now: $0.05
$0.05
50-Day Range
$0.04
MA: $0.05
$0.06
52-Week Range
$0.00
Now: $0.05
$0.12
Volume33,306 shs
Average Volume134,351 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.
Invictus MD Strategies logo

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IVITF
CUSIPN/A
CIKN/A
Phone844-800-6086
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

Invictus Announces Share Issuance
January 26, 2021 |  finance.yahoo.com
Invictus MD Strategies Corp Class A (IVITF)
November 2, 2020 |  nasdaq.com
IIROC Trading Halt - GENE.WT
October 21, 2020 |  markets.businessinsider.com
Invictus Announces Signing of a Purchase Agreement
June 22, 2020 |  finance.yahoo.com
Invictus MD Strategies Corp. - Change of Management
May 20, 2020 |  finance.yahoo.com
Invictus Announces Director Resignation
May 1, 2020 |  finance.yahoo.com
Invictus MD Strategies Corp. (IVITF)
March 24, 2020 |  finance.yahoo.com
Invictus MD Strategies Corp.
March 6, 2020 |  www.barrons.com
Invictus/Unified Cannabis financing deal crumbles
January 3, 2020 |  seekingalpha.com
INVICTUS ANNOUNCES CHANGE TO BOARD
December 13, 2019 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

0.56 out of 5 stars

Medical Sector

1433rd out of 2,019 stocks

Drug Manufacturers - Specialty & Generic Industry

34th out of 61 stocks

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.05
+0.01 (+28.57 %)
(As of 04/13/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IVITF News and Ratings via Email

Sign-up to receive the latest news and ratings for IVITF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Invictus MD Strategies (OTCMKTS:IVITF) Frequently Asked Questions

What stocks does MarketBeat like better than Invictus MD Strategies?

Wall Street analysts have given Invictus MD Strategies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Invictus MD Strategies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Invictus MD Strategies?

Invictus MD Strategies saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 4,900 shares, a decrease of 77.3% from the March 15th total of 21,600 shares. Based on an average daily volume of 64,300 shares, the days-to-cover ratio is presently 0.1 days.
View Invictus MD Strategies' Short Interest
.

How has Invictus MD Strategies' stock been impacted by Coronavirus?

Invictus MD Strategies' stock was trading at $0.03 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IVITF shares have increased by 50.0% and is now trading at $0.0450.
View which stocks have been most impacted by COVID-19
.

Who are Invictus MD Strategies' key executives?

Invictus MD Strategies' management team includes the following people:
  • Mr. Daniel Stanislav Kriznic, Founder and Advisor to Chairman & CEO (Age 42)
  • Mr. Aaron Bowden C.A., CPA, CPA, CA, Advisor
  • Imran Haider, Chief Exec. Officer
  • Ms. Elena Gershtein, Acting CFO & Controller
  • Mr. Marc Ripa, Chief Operating Officer
  • Ms. Brenda Mae Dixon, Chief Science Officer
  • Mr. Larry Heinzlmeir MBA, VP of Marketing & Communications
  • Mr. Gene Simmons, Chief Evangelist Officer (Age 71)

Who are some of Invictus MD Strategies' key competitors?

What is Invictus MD Strategies' stock symbol?

Invictus MD Strategies trades on the OTCMKTS under the ticker symbol "IVITF."

How do I buy shares of Invictus MD Strategies?

Shares of IVITF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invictus MD Strategies' stock price today?

One share of IVITF stock can currently be purchased for approximately $0.05.

What is Invictus MD Strategies' official website?

The official website for Invictus MD Strategies is invictus-md.com.

How can I contact Invictus MD Strategies?

The company can be reached via phone at 844-800-6086.


This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.